Major Depressive Disorder
Ketamine - A New Treatment for Major Depressive Disorder
According to the World Health Organization, 300 million people around the world suffer from depression. That includes 16.2 million adults in the United States (about 6.7 of adults in the country). Unfortunately, a great many of these cases of depression have proven treatment-resistant, even after multiple attempts and several different antidepressants.
Ketamine is an exciting new avenue for those seeking treatment because the effects of Ketamine’s relief on the symptoms of depression can be felt within hours, rather than the usual four-to-six weeks it takes for a standard antidepressant medication to take hold. Questions? Schedule a consultation here.